WGS250117P120000
- 29.80
- 0.000.00%
GeneDx Holdings Newsroom
Institutional Owners May Ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) Recent US$427m Market Cap Decline as Longer-term Profits Stay in the Green
Express News | GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Highest Quant-rated Mid-cap U.S. Stocks: WGS, EAT, AGX, and More
Express News | GeneDx Holdings Corp - Expects to Exceed Full Year 2024 Revenues Outlook of at Least $299 Million
Express News | GeneDx Q4 Revenue USD 92 Million Vs. IBES Estimate USD 80.2 Million
GeneDx Announces Preliminary 2024 Financial Results
Insider Sale: CHIEF FINANCIAL OFFICER of $WGS (WGS) Sells 900 Shares
GeneDx Holdings(WGS.US) Officer Sells US$3.33 Million in Common Stock
GeneDx Holdings(WGS.US) Officer Sells US$4.86 Million in Common Stock
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers
GeneDx Continues Its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients
GeneDx Holdings Is Maintained at Buy by TD Cowen
GeneDx Hldgs Analyst Ratings
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $118
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains?
Trending Stocks Today | MultiSensor AI Shoots up 38% Post-Market
GeneDx Holdings (NASDAQ:WGS) Has Debt But No Earnings; Should You Worry?
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday